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The Structure of Yersinia pestis V-Antigen,
an Essential Virulence Factor and
Mediator of Immunity against Plague
cation of a small number of bacterial proteins, termed
effectors, into the cytosol of eukaryotic cells (Ramamur-
thi and Schneewind, 2002). Collectively, these effectors
enable the bacterium to disarm the innate immune re-
sponse of the infected organism by interfering with sig-
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and Biological Physics nal transduction pathways that regulate actin cytoskele-
ton dynamics and inflammation (Cornelis, 2002). TheUniversity of Virginia
Charlottesville, Virginia 22908 deployment of cytotoxic effectors is regulated in part
by the action of the LcrV protein (V-antigen), an essential2 Macromolecular Crystallography Laboratory
National Cancer Institute at Frederick virulence factor with multiple functions. In the bacterial
cytoplasm, LcrV stimulates type III secretion by bindingFrederick, Maryland 21702
3 Procter & Gamble Pharmaceuticals to the negative regulatory protein LcrG and neutralizing
its ability to block secretion (Nilles et al., 1997). LcrV isHealth Care Research Center-Discovery
8700 Mason-Montgomery Road also exposed at the bacterial cell surface prior to contact
with mammalian cells (Fields et al., 1999; Pettersson etMason, Ohio 45040
al., 1999), and may play a role in cell-cell adhesion.
Some evidence suggests that LcrV can form pores in
eukaryotic cell membranes (Holmstro¨m et al., 2001),Summary
and, in conjunction with the Yersinia YopB and YopD
proteins, it probably forms the translocation pore throughThe LcrV protein (V-antigen) is a multifunctional viru-
which the effectors are delivered into mammalian cells.lence factor in Yersinia pestis, the causative agent of
Additionally, LcrV is both secreted into the extracellularplague. LcrV regulates the translocation of cytotoxic
milieu and translocated into eukaryotic cells (Fields andeffector proteins from the bacterium into the cytosol
Straley, 1999), where it exerts strong immunomodula-of mammalian cells via a type III secretion system,
tory effects (Nakajima et al., 1995; Nedialkov et al., 1997;possesses antihost activities of its own, and is also an
Welkos et al., 1998).active and passive mediator of resistance to disease.
The complex array of functions attributed to LcrV hasAlthough a crystal structure of this protein has been
effectively stymied efforts to elucidate its mechanismsactively sought for better understanding of its role
of action. Attempts to study structure-function relation-in pathogenesis, the wild-type LcrV was found to be
ships by deletion analysis and site-directed mutagene-recalcitrant to crystallization. We employed a surface
sis have yielded little useful information because theyentropy reduction mutagenesis strategy to obtain crys-
have been carried out without any knowledge about thetals of LcrV that diffract to 2.2 A˚ and determined its
tertiary structure of LcrV. With that in mind, we set outstructure. The refined model reveals a dumbbell-like
to determine the crystal structure of LcrV.molecule with a novel fold that includes an unexpected
coiled-coil motif, and provides a detailed three-dimen-
sional roadmap for exploring structure-function rela- Results and Discussion
tionships in this essential virulence determinant.
Structure Determination
Because crystals of the wild-type LcrV protein could notIntroduction
be obtained, we resorted to a novel strategy based on
mutational modification of surface properties to reduceThe three main plague pandemics are thought to have
excess conformational entropy, by replacing selectedbeen collectively responsible for over 200 million deaths
Lys and/or Glu residues with Ala. This approach was(Perry and Fetherston, 1997). The second pandemic
shown to be effective in model systems (Longeneckerwiped out over one-third of the population of Europe in
et al., 2001a; Mateja et al., 2002), and was used to crys-the 14th century, forever changing the course of Euro-
tallize novel proteins otherwise recalcitrant to crystalli-pean history. Today, plague is a reemerging disease,
zation (Longenecker et al., 2001b; Prag et al., 2003). Awith2000 outbreaks per annum that continue to occur
triple mutant (K40A/D41A/K42A) of LcrV yielded crystalsthroughout the world. The etiologic agent of plague,
that diffracted X-rays to 2.2 A˚ resolution. The structureYersinia pestis, is potentially one of the most dangerous
of LcrV was solved by the multiple anomalous diffractionbiological weapons, but the structural mechanisms that
(MAD) technique, using scattering from six seleniumgovern virulence in Y. pestis are not well understood,
atoms incorporated as selenomethionine (SeMet).and this seriously limits the potential to develop new
and effective drugs.
In Y. pestis, virulence is absolutely dependent on a Description of the Overall Structure
plasmid-encoded type III (contact-dependent) secretion The structure of LcrV resembles a dumbbell, with two
apparatus, which serves to direct the vectorial translo- globular domains on either end of a “grip” formed by a
coiled-coil motif (Figure 1). The N- and C termini of the
protein (residues 23–27 and 323–326) are not visible in*Correspondence: waughd@ncifcrf.gov
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Figure 1. Primary, Secondary, and Tertiary
Structure of Y. pestis LcrV
(A) Stereo view of the tertiary structure of
LcrV, with  helices and  strands colored
red and blue, respectively.
(B) Amino acid sequence of LcrV in single
letter code. Residues are numbered ac-
cording to their position in the full-length pro-
tein. The locations of  helices and  strands
are shown below the sequence in red and
blue, respectively. Dashed lines indicate re-
gions of the polypeptide for which no inter-
pretable electron density was observed. The
underlined residues are not part of the natural
LcrV sequence. The positions of the three
mutations in helix -1 and the C273S substi-
tution are marked by green triangles.
the electron density maps, nor is Tyr90 or the residues The Intramolecular Coiled Coil
LcrV has no known catalytic function, and its biologicalin two internal loops (49–63 and 260–275). The inherent
flexibility of these regions may have impeded efforts to activity is dependent on interactions with other proteins
including LcrG, a negative regulator of type III secretion.crystallize the wild-type protein. The N-terminal domain
(residues 1–146) consists of an antiparallel five-helix It has been proposed that the interaction between these
two proteins is mediated by the formation of an intermo-bundle that is embellished by a 310 helix (-3), a pair
of short, parallel  strands, and an antiparallel hairpin lecular coiled coil involving the N terminus of LcrG and
residues 148–169 of LcrV (Lawton et al., 2002), includingprotruding between helices -1 and -2, the apex of
which is disordered. The next segment of the polypep- the Lx3Lx2Lx3L motif in helix -7, a fingerprint of the
coiled-coil heptad repeat (Lupas, 1996). The crystaltide (residues 148–182) forms a long  helix (-7) that
connects the N-terminal domain to the second globular structure of LcrV confirms that residues 148–169 are
indeed helical, but the Lx3Lx2Lx3L motif is engaged bydomain. The latter is a less regular structure composed
of four short helices (8–11), two pairs of antiparallel the C-terminal helix (-12) in an intramolecular coiled
coil. However, the C-terminal helix is preceded by a very strands, and a considerable portion of extended sec-
ondary structure. Finally, the C-terminal residues 274– flexible loop (not resolved in the electron density map),
suggesting that it could be pulled apart and the molecule322, fold into a single long  helix (-12), part of which
(residues 280–305) forms an antiparallel coiled coil with may alternate between a closed (crystal structure) and
an open conformation. The latter, entropically more fa-residues 149–178 of helix -7. These two helices interact
via a hydrophobic “zipper” involving a L153x3L157x2 vorable, would be able to interact with other targets via
the now accessible hydrophobic surfaces of the twoL160x3L164 x2Y167x2I170x3I174x3L178 motif in -7 and a L280x3
V284x3T288xxL291 x2I294x3F298x3I302x2L305 motif in -12 (Figure 2). long helices, or form a head-to-tail dimer by a domain
swapping mechanism. Additional support for this ideaNeither the entire structure of LcrV nor the individual
globular domains are similar to other structures in the comes from the observation that LcrV is predominantly
dimeric in solution and that the 7.3 monoclonal antibodyProtein Data Bank. The closest structural relative identi-
fied by the DALI server (Holm and Sander, 1993) is prefol- raised against LcrV binds with 1:2 stoichiometry (Tito et
al., 2001). However, we note that 3754 A˚2 of surface areadin (PDB code: 1FXK), with a Z score of 5.3, but the
superficial similarity is limited to the two long helices is buried at the interface between helix -12 and the
remainder of the protein, suggesting that a very largethat form the grip between the globular domains.
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Figure 2. Stereo View of Electron Density
from the Coiled-Coil Region of LcrV, Con-
toured at 1.0 
change in free energy would be required for it to shift -12, which has a distinct kink that separates the helix
into two parts, and the presence of other hydrophobicfrom the closed to the open conformation.
The intramolecular coiled coil in LcrV is an unexpected residues rather than leucines at the hydrophobic inter-
face of the coiled-coil motif, may explain why the intra-structural feature. The majority of known coiled-coil pro-
teins are of eukaryotic origin. Bacterial proteins with molecular coiled coil in LcrV was overlooked.
coiled coils are normally found in proteins with eukary-
otic counterparts (Delahay and Frankel, 2002). Proteins Conserved Residues on the Surface of LcrV
Some clues about functionally important epitopes inthat transit the type III secretion systems of pathogenic
Gram-negative bacteria are unusual in that many of them LcrV can be gleaned by examining the locations of amino
acid residues that are conserved in its only known homo-are thought to contain coiled-coil motifs. The Yersinia
proteins YopB, YopD, YpkA, YopN, YscO, and YscL were log, Pseudomonas aeruginosa PcrV. The amino acid
sequences of LcrV and PcrV are 41% identical, and PcrVall predicted to have coils and/or multicoils, but LcrV
was conspicuously absent from this group (Delahay and is capable of complementing an LcrV deletion mutant
in Yersinia (Pettersson et al., 1999). The majority of theFrankel, 2002). The unorthodox stereochemistry of helix
Figure 3. Front and Back Views of the Sur-
face of LcrV
Amino acid residues that are conserved in P.
aeruginosa PcrV are colored brown.
Structure
304
Figure 4. A Crystal Contact Involving Resi-
dues 40–42 of LcrVmut41
Stereo view with electron density contoured
at 1.5 . Backbone carbon atoms are colored
black and side chain carbons are colored
gray. Nitrogen and oxygen atoms are col-
ored blue and red, respectively.
solvent-exposed residues that are conserved in both to disrupt the structural integrity of the whole protein,
so it is not surprising that nearly all deletion mutantsproteins are located on one face of the molecule, with
most of them projecting from helices -7, -10, and -12 were found to be nonfunctional in one or more assays.
A noteworthy exception is the deletion of residues 218–(Figure 3).
234, a hypervariable region in LcrV, which had no dis-
cernable effect on the activity of the protein (PetterssonStructure-Function Relationships
LcrV has been the object of extensive deletion mutagen- et al., 1999; Skrzypek and Straley, 1995). This region of
the polypeptide sequence adopts a  hairpin conforma-esis (DeBord et al., 2001; Fields et al., 1999; Holmstro¨m
et al., 2001; Pettersson et al., 1999; Sarker et al., 1998; tion that protrudes from the main body of the protein
into solvent, pointing away from the side of the moleculeSkrzypek and Straley, 1995). However, the crystal struc-
ture suggests that most deletions would be expected where most of the conserved residues are clustered.
Table 1. Crystallographic Data
SeMet SeMet SeMet Native
Inflection Peak Remote
2 1 3 4
Data Collection
Wavelength 0.9795 0.9790 0.9719 0.9715
Resolution (A˚) 2.6 (2.69–2.6)a 2.6 (2.69–2.6) 2.6 (2.69–2.6) 2.17 (2.25–2.17)
No. of total reflections 16,479 16,566 15,890 31,607
No. of unique reflections 8,061 8,056 7,982 14,116
Completeness (%) 97.5 (95.6) 97.7 (96.5) 96.5 (95.0) 95.9 (86.2)
Rmerge (%)b 6.2 (17.4) 6.4 (13.4) 6.0 (27.2) 7.7 (37.0)
I/(I) 11.2 (4.2) 11.4 (5.0) 10.6 (3.0) 12.5 (2.0)
Phasing Statistics
Phasing powerc, iso/ano 0.56/1.5 —/1.6 0.49/1.1
Refinement statistics
Model composition 250 residues  242 waters
Resolution limits (A˚) 30–2.17
Reflections in working/test sets 12,733/1,383
Reflections in final refinement 14,116
Rd/Rfree (%) 21.7/28.4
Final Rd (%) 22.4
Bond (A˚)/angle () rms 0.008/1.877
Ramachandran Plot
Most favored regions 90.8%
Additional allowed regions 9.2%
a The numbers in parentheses describe the relevant value for the last resolution shell.
b Rmerge |Ii 	 
I|/I where Ii is the intensity of the ith observation and 
I is the mean intensity of the reflections.
c Phasing power  rms (|Fh|/E), where |Fh| is the heavy atom structure factor amplitude and E is residual lack of closure error.
d R  ||Fobs| 	 |Fcalc||/|Fobs|, crystallographic R factor, and Rfree  ||Fobs| 	 |Fcalc||/|Fobs| where all reflections belong to a test set of randomly
selected data.
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whereas the truncated LcrV protein containing only the C273S muta-The structure may also provide some insight into the
tion did not crystallize under any of these conditions. However,roots of immunogenicity of LcrV. Immunization with re-
only one of the mutants, LcrVmut41 (K40A/D41A/K42A), producedcombinant LcrV, or passive immunization with antibod-
crystals that were suitable for data collection. The best crystals of
ies against it, confers a high degree of protection (Ander- LcrVmut41 were grown by the sitting-drop vapor-diffusion tech-
son et al., 1996; Une and Brubaker, 1984). It has been nique at room temperature. The original crystals were obtained from
Hampton Research Crystal Screen I. This condition was later opti-shown that the protective epitope(s) recognized by the
mized to 26% (w/v) PEG-5000 MME, 200 mM sodium acetate, 100rabbit anti-LcrV antibodies are located within the central
mM Tris-HCl (pH 8.7) with a protein concentration of 30 mg ml	1. Theregion of LcrV (residues 135–275). The crystal structure
SeMet crystals were also grown by the sitting-drop vapor-diffusionreveals that this includes helix -7 and the C-terminal
technique at 21C by mixing equal volumes of 22 mg ml	1 protein
globular domain of the protein. and reservoir solution containing 26% (w/v) PEG-4000, 100 mM Tris-
HCl (pH 8.5), 200 mM sodium acetate. Diffraction quality crystals
grew in 3–5 days, after which they began to deteriorate. The crystalsA Crystal Contact Involving the Mutated Residues
of LcrVmut41 belong to space group P1 with the following unit cellFinally, we note that the refined model of the LcrV struc-
dimensions: a  35.87 A˚, b  45.10 A˚, c  46.93 A˚,   76.2,  ture reveals how the triple surface mutation (K41A/
78.4,   77.1.D42A/K43A) generated an epitope that mediates crystal
contacts between neighboring molecules. These three
Data Collection and Structure Solution
residues constitute the last turn of helix -1, which forms The structure of LcrVmut41 was determined by using the phases
an exposed knob that fits between two adjacent mole- obtained from a MAD experiment with data collected at the selenium
cules in the P1 crystal lattice (Figure 4). We surmise that edge, the inflection point, and remote high-energy wavelengths (Ta-
ble 1). These three data sets were collected at NSLS beam line X9Athe absence of the long side chains that occupy these
to 2.6 A˚ resolution at 100 K, using a single SeMet-substituted crystalpositions in the wild-type structure allowed the protein
frozen in a cryo solution consisting of 32% (w/v) PEG-4000, 200 mMmolecules to approach one another without excessive
sodium acetate, 100 mM Tris-HCl (pH 8.5). X-ray diffraction data
loss of conformational entropy. Crystal contacts involv- were processed and scaled with the HKL2000 software package
ing mutated residues have been observed in every case (Otwinowski and Minor, 1997). Anomalous differences from the sele-
where surface entropy reduction mutagenesis has suc- nium edge data set were used to locate the six Se atoms with
SHELXD (Schneider and Sheldrick, 2002). The phases were subse-ceeded thus far, lending credence to the underlying
quently refined with SHARP (de la Fortelle and Bricogne, 1997). Apremise of the strategy. The long-awaited crystal struc-
partial model was then built into interpretable Fourier electron den-ture of LcrV is a testament to the power of this technique.
sity maps calculated with the phases obtained from SHARP. Refine-
ment was initially performed with Refmac (Murshudov et al., 1997).Experimental Procedures
The final refinement was performed with REFMAC5 and SHELXL
(Sheldrick and Schneider, 1997), using 2.2 A˚ data collected at NSLSSite-Directed Mutagenesis
beam line X9B from a single crystal of native LcrVmut41 frozen atAmino acid substitutions in LcrV were created by the QuikChange
100 K in 32% (w/v) PEG 8000, 200 mM sodium acetate, 100 mMmethod (Stratagene), using the MBP-LcrV(1-23/C273S)-His6 ex-
Tris-HCl (pH 8.7). The final model, which includes 250 residues ofpression vector pKM837/C273S as the template. Five cluster mu-
the protein and 242 water molecules, satisfies the quality criteriatants (K40A/D41A/K42A, K54A/D55A/E57A, K72A/K73A, E155A/
limits of the program PROCHECK (Laskowski et al., 1993).E156A/E159A, and K214A/E217A/K218A) were tested for crystalliza-
tion within the framework of an N-terminally truncated (1-23) LcrV
Acknowledgmentsprotein, which is the principal digestion product resulting from lim-
ited proteolysis of the full-length protein with thermolysin (data not
We thank Florian Schubot for helping to create Figure 3. This workshown). At the same time, the single cysteine in LcrV (Cys273) was
was funded in part by NIGMS (grant GM62615 to Z.S.D.). We thankreplaced with a serine residue to prevent covalent dimerization of
Marcin Paduch (University of Wroclaw) for his help with the designthe protein which proved to be troublesome during purification.
of the LcrV mutants and structure prediction methods.
Protein Expression and Purification
The LcrV mutants were overproduced in Escherichia coli BL21(DE3)- Received: September 12, 2003
RIL cells (Stratagene). The cells were grown at 37C to midlog phase Revised: October 17, 2003
in Luria Broth supplemented with 100 g ml	1 ampicillin and 30 g Accepted: October 18, 2003
ml	1 chloramphenicol, at which point IPTG was added to a final Published: February 10, 2004
concentration of 1 mM. Six hours later, the cells were pelleted by
centrifugation, resuspended in phosphate-buffered saline (pH 8)
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